JP2004508006A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004508006A5 JP2004508006A5 JP2001558068A JP2001558068A JP2004508006A5 JP 2004508006 A5 JP2004508006 A5 JP 2004508006A5 JP 2001558068 A JP2001558068 A JP 2001558068A JP 2001558068 A JP2001558068 A JP 2001558068A JP 2004508006 A5 JP2004508006 A5 JP 2004508006A5
- Authority
- JP
- Japan
- Prior art keywords
- angiogenic disease
- plasminogen
- plasmin
- animal
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000002491 angiogenic effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 102000013566 Plasminogen Human genes 0.000 description 1
- 108010051456 Plasminogen Proteins 0.000 description 1
- 102000001938 Plasminogen Activators Human genes 0.000 description 1
- 108010001014 Plasminogen Activators Proteins 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229940012957 plasmin Drugs 0.000 description 1
- 229940127126 plasminogen activator Drugs 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50039700A | 2000-02-08 | 2000-02-08 | |
| PCT/US2001/004021 WO2001058921A2 (en) | 2000-02-08 | 2001-02-08 | Methods and compositions for generating angiostatin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004508006A JP2004508006A (ja) | 2004-03-18 |
| JP2004508006A5 true JP2004508006A5 (https=) | 2008-04-03 |
Family
ID=23989238
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001558068A Pending JP2004508006A (ja) | 2000-02-08 | 2001-02-08 | アンギオスタチンを生成するための方法および組成物 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1263452A4 (https=) |
| JP (1) | JP2004508006A (https=) |
| AU (1) | AU2001234926A1 (https=) |
| CA (1) | CA2400497A1 (https=) |
| WO (1) | WO2001058921A2 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011004011A1 (en) | 2009-07-10 | 2011-01-13 | Thrombogenics Nv | Variants of plasminogen and plasmin |
| JP6085568B2 (ja) | 2011-01-05 | 2017-02-22 | スロンボジェニックス・ナムローゼ・フェンノートシャップＴｈｒｏｍｂｏＧｅｎｉｃｓ ＮＶ | プラスミノーゲンおよびプラスミンの変異体 |
| US9644196B2 (en) | 2011-08-12 | 2017-05-09 | Thrombogenics Nv | Plasminogen and plasmin variants |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1988003030A1 (en) * | 1986-10-31 | 1988-05-05 | Moscatelli David A | METHOD FOR INDUCING ENDOGENOUS PRODUCTION OF TISSUE PLASMINOGEN ACTIVATOR (tPA) |
| NZ230808A (en) * | 1988-10-24 | 1993-04-28 | Squibb & Sons Inc | Pharmaceutical compositions and combinations containing an angiotensin-converting enzyme inhibitor and a thrombolytic agent |
| US5801012A (en) * | 1996-09-17 | 1998-09-01 | Northwestern University | Methods and compositions for generating angiostatin |
-
2001
- 2001-02-08 WO PCT/US2001/004021 patent/WO2001058921A2/en not_active Ceased
- 2001-02-08 CA CA002400497A patent/CA2400497A1/en not_active Abandoned
- 2001-02-08 EP EP01907105A patent/EP1263452A4/en not_active Withdrawn
- 2001-02-08 JP JP2001558068A patent/JP2004508006A/ja active Pending
- 2001-02-08 AU AU2001234926A patent/AU2001234926A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004525194A5 (https=) | ||
| CY2020003I2 (el) | Anti-il-12 αντισωματα, συνθεσεις, μεθοδοι και χρησεις για την θεραπευτικη αγωγη της παθολογιας του crohn | |
| CY1118651T1 (el) | Αζακυκλικες ενωσεις για χρηση στην θεραπευτικη αντιμετωπιση ασθενειων που σχετιζονται με τη σεροτονινη | |
| WO2004037205A8 (en) | LOW DOSE METHODS FOR TREATING DISORDERS IN WHICH TNFα ACTIVITY IS DETRIMENTAL | |
| TW200505901A (en) | Muscarinic agonists | |
| DE60115842D1 (de) | Ventilanordnung | |
| DE60138468D1 (de) | Cyanophenoxy-carbonsäuren und zusammensetzungen für die freisetzung aktiver substanzen | |
| WO2002049413A3 (en) | Thrombopoietin mimetics | |
| WO2004110380A3 (en) | Treatment of immune-mediated disorders with active vitamin d compounds alone or in combination with other therapeutic agents | |
| IT1319240B1 (it) | Procedimento per la oligomerizzazione selettiva dell'etilene. | |
| EP1429659A4 (en) | ULTRASOUND THERAPY | |
| JP2004508006A5 (https=) | ||
| JP2002531135A5 (https=) | ||
| SE0004827D0 (sv) | Therapeutic compounds | |
| RU2001118219A (ru) | Ингибитор ангиогенеза | |
| ZA200210361B (en) | Method of administering bishosphonates. | |
| SE0100873D0 (sv) | Method of treatment | |
| AP1777A (en) | Use of topical compositions for the control of microbial diseases of the nail. | |
| MA26931A1 (fr) | Agent therapeutique cristallin. | |
| NO20032035D0 (no) | Terapeutiske midler for heratokonjunktivitis sykdommer omfattende farnesyleddiksyre som aktiv ingrediens | |
| EP1765990A4 (en) | THERAPEUTIC, PROPHYLACTIC AND DIAGNOSTIC AGENTS AGAINST HEPATITIS B | |
| JP2006501269A5 (https=) | ||
| JP2002533400A5 (https=) | ||
| ATE342882T1 (de) | Kompaktierter milchsäurementhylester | |
| FR2854803B1 (fr) | Composition vaccinale comprenant du phosphate de fer a titre d'adjuvent vaccinal. |